• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微创 McKeown 食管切除术治疗食管鳞癌患者的纵向患者报告结局。

Longitudinal patient-reported outcomes after minimally invasive McKeown esophagectomy for patients with esophageal squamous cell carcinoma.

机构信息

Department of Thoracic Surgery, Sichuan Cancer Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, 610041, People's Republic of China.

出版信息

Support Care Cancer. 2024 Mar 20;32(4):237. doi: 10.1007/s00520-024-08428-z.

DOI:10.1007/s00520-024-08428-z
PMID:38509239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10954946/
Abstract

PURPOSE

Surgery for esophageal squamous cell carcinoma (ESCC) is characterized by a poor prognosis and high complication rate, resulting in a heavy symptom burden and poor health-related quality of life (QOL). We evaluated longitudinal patient-reported outcomes (PROs) to analyze the correlations between symptoms and QOL and their changing characteristics during postoperative rehabilitation.

METHODS

We investigated patients with ESCC who underwent minimally invasive McKeown esophagectomy at Sichuan Cancer Hospital between April 2019 and December 2019. Longitudinal data of the clinical characteristics and PROs were collected. The MD Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer (EORTC) QOL questionnaires were used to assess symptoms and QOL and compare the trajectories of PROs during the investigation.

RESULTS

A total of 244 patients with ESCC were enrolled in this study. Regarding QOL, role and emotional functions returned to baseline at 1 month after surgery, and cognitive and social functions returned to baseline at 3 months after surgery. However, physical function and global QOL did not return to baseline at 1 year after surgery. At 7 days and 1, 3, 6, and 12 months after surgery, the main symptoms of the patients were negatively correlated with physical, role, emotional, cognitive, and social functions and the overall health status (P < 0.05).

CONCLUSION

Patients with ESCC experience reduced health-related QOL and persisting symptoms after minimally invasive McKeown esophagectomy, but a recovery trend was observed within 1 month. The long-term QOL after esophagectomy is acceptable.

摘要

目的

食管鳞状细胞癌(ESCC)的手术特点是预后不良和高并发症发生率,导致症状负担沉重,健康相关生活质量(QOL)较差。我们评估了纵向患者报告的结果(PROs),以分析症状与 QOL 之间的相关性及其在术后康复过程中的变化特征。

方法

我们调查了 2019 年 4 月至 2019 年 12 月在四川肿瘤医院接受微创 McKeown 食管切除术的 ESCC 患者。收集了患者的临床特征和 PROs 的纵向数据。使用 MD Anderson 症状量表和欧洲癌症研究与治疗组织(EORTC)生活质量问卷评估症状和 QOL,并比较了调查期间 PROs 的轨迹。

结果

本研究共纳入 244 例 ESCC 患者。关于 QOL,角色和情绪功能在手术后 1 个月恢复到基线,认知和社会功能在手术后 3 个月恢复到基线。然而,身体功能和总体 QOL在手术后 1 年未恢复到基线。手术后 7 天和 1、3、6 和 12 个月,患者的主要症状与身体、角色、情绪、认知和社会功能以及整体健康状况呈负相关(P<0.05)。

结论

微创 McKeown 食管切除术后,ESCC 患者的健康相关 QOL 降低且症状持续存在,但在 1 个月内观察到恢复趋势。手术后的长期 QOL 是可以接受的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/af9d3ef1595d/520_2024_8428_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/4e739451ba97/520_2024_8428_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/543ab70efc82/520_2024_8428_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/bd868aeca37d/520_2024_8428_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/af9d3ef1595d/520_2024_8428_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/4e739451ba97/520_2024_8428_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/543ab70efc82/520_2024_8428_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/bd868aeca37d/520_2024_8428_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf4/10954946/af9d3ef1595d/520_2024_8428_Fig4_HTML.jpg

相似文献

1
Longitudinal patient-reported outcomes after minimally invasive McKeown esophagectomy for patients with esophageal squamous cell carcinoma.微创 McKeown 食管切除术治疗食管鳞癌患者的纵向患者报告结局。
Support Care Cancer. 2024 Mar 20;32(4):237. doi: 10.1007/s00520-024-08428-z.
2
Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.微创 Ivor Lewis 食管切除术与左开胸食管切除术治疗食管鳞癌的比较:倾向评分匹配分析。
BMC Cancer. 2019 May 27;19(1):500. doi: 10.1186/s12885-019-5656-7.
3
Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.新辅助治疗后食管鳞状细胞癌患者的微创与开放食管切除术对比
BMC Cancer. 2021 Feb 9;21(1):145. doi: 10.1186/s12885-021-07867-9.
4
Short-Term Outcomes and Quality of Life Following Minimally Invasive Esophagectomy in a Tertiary Care Center in Southern India.印度南部一家三级医疗中心微创食管切除术后的短期结局和生活质量
Cureus. 2023 Nov 22;15(11):e49245. doi: 10.7759/cureus.49245. eCollection 2023 Nov.
5
Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy).机器人辅助食管切除术(RAE)与传统微创食管切除术(MIE)治疗可切除的食管鳞癌:一项多中心前瞻性随机对照试验的方案(RAMIE 试验,机器人辅助微创食管切除术)。
BMC Cancer. 2019 Jun 21;19(1):608. doi: 10.1186/s12885-019-5799-6.
6
Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes.机器人辅助微创食管切除术在治疗食管鳞癌方面真的比电视辅助微创食管切除术具有淋巴结清扫优势吗?基于短期结果的倾向评分匹配分析。
Dis Esophagus. 2019 Jul 1;32(7). doi: 10.1093/dote/doy110.
7
Long-term health-related quality of life after McKeown and Ivor Lewis esophagectomy for esophageal carcinoma.食管癌经麦克尤恩式和艾弗·刘易斯式食管切除术后与健康相关的长期生活质量
Dis Esophagus. 2020 Nov 18;33(11). doi: 10.1093/dote/doaa022.
8
Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study.机器人辅助与胸腹腔镜联合McKeown食管癌切除术治疗食管鳞状细胞癌的短期和中期结果:一项倾向评分匹配研究
Dis Esophagus. 2020 Jun 15;33(6). doi: 10.1093/dote/doz080.
9
Learning curve in relation to health-related quality of life in long-term, disease free survivors after McKeown minimally invasive esophagectomy.麦克基翁微创食管切除术长期无病生存者健康相关生活质量的学习曲线。
Surg Endosc. 2024 Feb;38(2):671-678. doi: 10.1007/s00464-023-10553-5. Epub 2023 Nov 27.
10
Occurrence and recovery of vocal cord paralysis after minimally invasive McKeown esophagectomy, risk factors, and clinical outcome.微创 McKeown 食管切除术后面瘫的发生与恢复、危险因素和临床结果。
Surgery. 2024 Sep;176(3):713-720. doi: 10.1016/j.surg.2024.05.020. Epub 2024 Jun 17.

引用本文的文献

1
Analysis of the impact of minimally invasive esophagectomy on quality of life and functional prognosis in patients with esophageal squamous cell carcinoma: A retrospective comparative study.微创食管癌切除术对食管鳞状细胞癌患者生活质量和功能预后的影响分析:一项回顾性比较研究。
J Cardiothorac Surg. 2025 May 30;20(1):250. doi: 10.1186/s13019-025-03485-9.
2
Factors associated with functional ability in patients with esophageal cancer undergoing chemoradiotherapy: a prospective longitudinal study.与接受放化疗的食管癌患者功能能力相关的因素:一项前瞻性纵向研究。
Support Care Cancer. 2024 Nov 26;32(12):825. doi: 10.1007/s00520-024-09050-9.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Symptom clusters and impact on quality of life in esophageal cancer patients.食管癌患者的症状群及其对生活质量的影响。
Health Qual Life Outcomes. 2022 Dec 23;20(1):168. doi: 10.1186/s12955-022-02084-9.
3
Long-Term Quality of Life After Esophagectomy for Esophageal Cancer.食管癌切除术后的长期生活质量
Ann Thorac Surg. 2023 Jan;115(1):200-208. doi: 10.1016/j.athoracsur.2022.07.029. Epub 2022 Aug 2.
4
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.食管癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Oct;33(10):992-1004. doi: 10.1016/j.annonc.2022.07.003. Epub 2022 Jul 29.
5
Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis.新辅助治疗和食管切除术后辅助治疗在食管癌患者中的作用:系统评价和荟萃分析。
Ann Surg. 2022 Jan 1;275(1):91-98. doi: 10.1097/SLA.0000000000005227.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols.临床试验方案中患者报告结局的指南。
JAMA. 2018 Feb 6;319(5):450-451. doi: 10.1001/jama.2017.21541.
8
Symptom Severity and Quality of Life Among Long-term Colorectal Cancer Survivors Compared With Matched Control Subjects: A Population-Based Study.长期结直肠癌幸存者与匹配对照受试者的症状严重程度和生活质量比较:一项基于人群的研究。
Dis Colon Rectum. 2018 Mar;61(3):355-363. doi: 10.1097/DCR.0000000000000972.
9
Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.老年局部晚期食管癌患者的治疗利用情况及结局:美国国立癌症数据库综述
Cancer Med. 2017 Dec;6(12):2886-2896. doi: 10.1002/cam4.1250. Epub 2017 Nov 15.
10
Making Patients and Doctors Happier - The Potential of Patient-Reported Outcomes.让患者和医生更满意——患者报告结局的潜力
N Engl J Med. 2017 Oct 5;377(14):1309-1312. doi: 10.1056/NEJMp1707537.